NCT02498236View on ClinicalTrials.gov

Target Engagement for Oxytocin: Dose Ranging Study

NACompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions

Schizophrenia Spectrum

Interventions

DRUG

Intranasal Oxytocin

All Listed Sponsors

lead

University of California, Los Angeles

OTHER

NCT02498236 - Target Engagement for Oxytocin: Dose Ranging Study | Biotech Hunter | Biotech Hunter